Rishang Deoras has been promoted to Global Director – Diabetes Commercial Unit at Novo Nordisk, marking another significant milestone in his distinguished multi-decade career across the pharmaceutical and FMCG sectors. With extensive global and country-level experience in sales, marketing, and lifecycle management, he has consistently led high-performing teams and driven strategic commercial growth across leading therapeutic areas.
At Novo Nordisk, Rishang has led critical global marketing and commercial initiatives across the diabetes and obesity portfolio—steering strategies for key brands like Rybelsus®, Ozempic®, and Wegovy™, among others. He has also overseen portfolios within insulins, rare diseases, and medical devices, managing multifunctional teams across global market access, forecasting, HEOR, digital health commercialization, and value strategy. His ability to formulate and execute omnichannel tactics, new launches, and LoE strategies has delivered transformative impact at a global scale.
Rishang’s leadership journey spans across renowned organizations such as AstraZeneca, GSK Consumer Healthcare, Zydus Cadila, and now Novo Nordisk, where he has driven breakthrough performance in cardiovascular, renal, metabolic, and nutrition segments. His strategic direction has shaped category-leading brands like Forxiga® and Horlicks®, earning recognition from executive leadership for outstanding business outcomes. His experience also includes navigating complex global business structures, managing P&L, leading GBS and GCC operations, and presenting at international executive forums.
As a general management professional with strong capabilities in talent development, international business, and digital transformation, Rishang continues to exemplify visionary leadership in improving global patient outcomes. His new role reflects a deep-rooted commitment to driving commercial excellence and innovation within the pharmaceutical industry.
Novo Nordisk congratulates Rishang Deoras on this well-deserved appointment and looks forward to the continued global impact under his leadership.